OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
60
Results
Show all
Save search
Copy query
Show results for
Unknown
(54)
Transcriptomics
(4)
Metabolomics
(2)
Organisms
Homo sapiens
(4)
Repository
biostudies-arrayexpress
(4)
MetaboLights
(2)
Technology Type
Mass spectrometry
(2)
Instrument Platform
Q Exactive
(2)
Publication Date
2015
(3)
2024
(2)
2018
(1)
CHEBI ID
CHEBI:90332
(2)
CHEBI:74767
(2)
CHEBI:134538
(2)
CHEBI:83063
(2)
CHEBI:166485
(2)
CHEBI:28623
(2)
CHEBI:11805
(2)
CHEBI:176456
(2)
CHEBI:76341
(2)
CHEBI:133693
(2)
CHEBI:139374
(2)
CHEBI:133677
(2)
CHEBI:84814
(2)
CHEBI:64681
(2)
CHEBI:21054
(2)
CHEBI:37564
(2)
CHEBI:73027
(2)
CHEBI:143243
(2)
CHEBI:1606
(2)
CHEBI:191640
(2)
CHEBI:19928
(2)
CHEBI:2869
(2)
CHEBI:48929
(2)
CHEBI:25013
(2)
CHEBI:17072
(2)
CHEBI:36315
(2)
CHEBI:68434
(2)
CHEBI:145970
(2)
CHEBI:68505
(2)
CHEBI:165856
(2)
Metabolite Name
Cysteinylglycine disulfide*
(2)
Prolylhydroxyproline
(2)
4-hydroxycinnamate sulfate
(2)
Ribulonate/xylulonate/lyxonate*
(2)
5'- GMP
(2)
Dihomolinoleate (20:2n6)
(2)
2-palmitoleoyl-GPC* (16:1)*
(2)
1-palmitoyl-GPI* (16:0)
(2)
1-linoleoyl-GPI* (18:2)*
(2)
1-arachidonoyl-GPI* (20:4)*
(2)
Linoleoylcholine*
(2)
Campesterol
(2)
Propionylcarnitine (C3)
(2)
Ascorbic acid 3-sulfate*
(2)
3-amino-2-piperidone
(2)
3-formylindole
(2)
3-hydroxyoleoylcarnitine
(2)
3-hydroxypalmitoylcarnitine
(2)
2'-O-methyluridine
(2)
Oleoylcholine
(2)
Ascorbic acid 2-sulfate
(2)
Isocitric lactone
(2)
Palmitoylcholine
(2)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)*
(2)
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*
(2)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)*
(2)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*
(2)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*
(2)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*
(2)
2-hydroxybutyrate/2-hydroxyisobutyrate
(2)
Study type
Transcription profiling by array
(4)
Release Date
2025
(11)
2022
(11)
2023
(7)
2015
(5)
2021
(5)
2019
(5)
2020
(4)
2026
(2)
2024
(2)
2013
(2)
2018
(1)
2017
(1)
2011
(1)
2008
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.
Not available
S-EPMC4351529
|
biostudies-literature
Cite
Renal primordia activate kidney regenerative events in a rat model of progressive renal disease.
Not available
S-EPMC4374877
|
biostudies-literature
Cite
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.
Not available
S-EPMC3049181
|
biostudies-literature
Cite
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.
Not available
S-EPMC3722081
|
biostudies-literature
Cite
Real World Incidence and Etiology of Infectious Complications in Adults With Ph‐Negative Acute Lymphoblastic Leukemia Treated With the Pediatric‐Inspired GIMEMA LAL1913 Program. A Campus All Study
Not available
S-EPMC12337620
|
biostudies-literature
Cite
Fatty Acid Profile and Antioxidant Status Fingerprint in Sarcopenic Elderly Patients: Role of Diet and Exercise.
Not available
S-EPMC6893529
|
biostudies-literature
Cite
Musculoskeletal ultrasound for treating rheumatoid arthritis to target-a systematic literature review.
Not available
S-EPMC9707059
|
biostudies-literature
Cite
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort.
Not available
S-EPMC12275189
|
biostudies-literature
Cite
Intermittent fasting enhances cisplatin-metformin efficacy in therapy-resistant ovarian cancer PDXs.
Not available
S-EPMC12803865
|
biostudies-literature
Cite
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Not available
S-EPMC9349965
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
